Cargando…

Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?

Endometrial cancer is one of the most common malignant diseases in women worldwide, with an incidence of 5.9%. Thus, it is the most frequent cancer of the female genital tract, with more than 34,000 women dying, in Europe and North America alone. Endometrial Cancer Stem Cells (CSC) might be drivers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banz-Jansen, Constanze, Helweg, Laureen P., Kaltschmidt, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955970/ https://www.ncbi.nlm.nih.gov/pubmed/35328833 http://dx.doi.org/10.3390/ijms23063412

Ejemplares similares

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
por: Barros, Inês, et al.
Publicado: (2020)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
por: Laine, Christopher G., et al.
Publicado: (2020)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
por: Alenazi, Aqeel M., et al.
Publicado: (2023)

Coronary Artery Bypass Grafting in Acute Ischemic Heart Failure: Where do We Stand? (And Where Should We Go?)
por: Kubrusly, Fernando B., et al.
Publicado: (2018)

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
por: Harari, Sergio, et al.
Publicado: (2015)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Neutrino Masses and Mixing: Where We Stand and Where We are Going
por: Gonzalez-Garcia, M.C.
Publicado: (2002)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

Respondent driven sampling—where we are and where should we be going?
por: White, Richard G, et al.
Publicado: (2012)

COVID-19 Vaccination. Where Are We and Where Should We Go?
por: Peña-Otero, David
Publicado: (2022)

The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
por: Werner, Rudolf A., et al.
Publicado: (2018)

Selenium, Stroke, and Infection: A Threefold Relationship; Where Do We Stand and Where Do We Go?
por: Liampas, Andreas, et al.
Publicado: (2023)

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
por: Radzina, Maija, et al.
Publicado: (2023)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

Spontaneous Resolution of Portal Vein Thrombosis in Cirrhosis: Where do we Stand, and Where will we Go?
por: Qi, Xingshun, et al.
Publicado: (2014)

Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
por: Chung, Wei-Hsin, et al.
Publicado: (2023)

Where Do We Stand?
Publicado: (1891)

Drug misuse in India: Where do we stand & where to go from here?
por: Avasthi, Ajit, et al.
Publicado: (2019)

EEG Recordings as Biomarkers of Pain Perception: Where Do We Stand and Where to Go?
por: Zis, Panagiotis, et al.
Publicado: (2022)

STI management and control in Latin America: where do we stand and where do we go from here?
por: Garcia, Patricia J, et al.
Publicado: (2011)

Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go
por: Yu, Yunxian
Publicado: (2023)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

High-energy physics after the discovery of the W and Z particles: where do we stand? Where do we go?
por: Van Hove, Léon Charles Prudent
Publicado: (1983)

Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here
por: Vassalle, Cristina, et al.
Publicado: (2020)

Implementation of Psychologically Informed Physical Therapy for Low Back Pain: Where Do We Stand, Where Do We Go?
por: Ballengee, Lindsay A, et al.
Publicado: (2021)

Structural and functional genomics in Old World camels—where do we stand and where to go
por: Burger, Pamela A, et al.
Publicado: (2022)

Systematic Reviews in Occupational Health and Safety: where are we and where should we go?
por: Verbeek, Jos, et al.
Publicado: (2019)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Stem Cell Therapy in Bladder Dysfunction: Where Are We? And Where Do We Have to Go?
por: Kim, Jae Heon, et al.
Publicado: (2013)

Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
por: Németh, Tamás, et al.
Publicado: (2022)

Pembrolizumab in endometrial cancer: Where we stand now
por: Aravantinou-Fatorou, Aikaterini, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_37aul9ofu4ut1dv0ptuupovp0h